IVD Medical Holding (HKSE:01931) EPS (Diluted) : HK$0.19 (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is IVD Medical Holding EPS (Diluted)?

IVD Medical Holding's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was HK$0.11. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.19.

IVD Medical Holding's EPS (Basic) for the six months ended in Dec. 2023 was HK$0.11. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.19.

IVD Medical Holding's EPS without NRI for the six months ended in Dec. 2023 was HK$0.12. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.20.

During the past 12 months, IVD Medical Holding's average EPS without NRIGrowth Rate was 12.70% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 9.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was -3.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, IVD Medical Holding's highest 3-Year average EPS without NRI Growth Rate was 72.90% per year. The lowest was -10.80% per year. And the median was 9.40% per year.

IVD Medical Holding EPS (Diluted) Historical Data

The historical data trend for IVD Medical Holding's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IVD Medical Holding EPS (Diluted) Chart

IVD Medical Holding Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Diluted)

Get a 7-Day Free Trial

0.24

0.14

0.16

0.17

0.19

IVD Medical Holding Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EPS (Diluted)	Get a 7-Day Free Trial									0.09	0.07	0.11	0.08	0.11

Competitive Comparison of IVD Medical Holding's EPS (Diluted)

For the Medical Distribution subindustry, IVD Medical Holding's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IVD Medical Holding's PE Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, IVD Medical Holding's PE Ratio distribution charts can be found below:

* The bar in red indicates where IVD Medical Holding's PE Ratio falls into.

IVD Medical Holding EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

IVD Medical Holding's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(260.498	-	0)	/	1351.885
	=	0.19

IVD Medical Holding's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(147.829	-	0)	/	1351.879
	=	0.11

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.19

IVD Medical Holding (HKSE:01931) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

IVD Medical Holding EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of IVD Medical Holding's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

IVD Medical Holding (HKSE:01931) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » IVD Medical Holding Ltd (HKSE:01931) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 299, Bisheng Road, Room 602, Building 6, Zhangjiang Hi-Tech Park, Pudong New Area District, Shanghai, CHN

Website

http://www.ivdholding.com

IVD Medical Holding Ltd is principally engaged in the sale and manufacture of medical equipment and consumables and the provision of consultancy and maintenance services related to medical equipment. It has three segments. The distribution business, which is the key revenue driver, involves the trading of IVD analysers, reagents, and other consumables to customers such as distributors, hospitals and healthcare institutions, and logistics providers. The After-sales Services provided by Vastec include maintenance and repair services, installation services and end-customer training. Its Self-branded Products Business, distributes its self-developed IVD products under its own brand which includes IVD analysers and reagents under the IVD testing category of Point-of-care testing.

IVD Medical Holding (HKSE:01931) Headlines

No Headlines